Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30016634HIVENSG00000096968.14protein_codingJAK2YesNo3717O60674
TVIS30009687HIVENSG00000096968.14protein_codingJAK2YesNo3717O60674
TVIS30013696HIVENSG00000096968.14protein_codingJAK2YesNo3717O60674
TVIS30011080HIVENSG00000096968.14protein_codingJAK2YesNo3717O60674
TVIS30009688HIVENSG00000096968.14protein_codingJAK2YesNo3717O60674
TVIS30018658HIVENSG00000096968.14protein_codingJAK2YesNo3717O60674
TVIS30074094HIVENSG00000096968.14protein_codingJAK2YesNo3717O60674
TVIS30070676HIVENSG00000096968.14protein_codingJAK2YesNo3717O60674
TVIS30070677HIVENSG00000096968.14protein_codingJAK2YesNo3717O60674
TVIS20011341HPVENSG00000096968.14protein_codingJAK2YesNo3717O60674
TCGA Plot Options
Drug Information
GeneJAK2
DrugBank IDDB11763
Drug NameMomelotinib
Target IDBE0002408
UniProt IDO60674
Regulation Typeinhibitor
PubMed IDs31450973
CitationsXu L, Feng J, Gao G, Tang H: Momelotinib for the treatment of myelofibrosis. Expert Opin Pharmacother. 2019 Nov;20(16):1943-1951. doi: 10.1080/14656566.2019.1657093. Epub 2019 Aug 26.
GroupsApproved; Investigational
Direct ClassificationPhenylpyrimidines
SMILESO=C(NCC#N)C1=CC=C(C=C1)C1=CC=NC(NC2=CC=C(C=C2)N2CCOCC2)=N1
Pathways
PharmGKB
ChEMBLCHEMBL1078178